Page last updated: 2024-10-30

letrozole and Low Back Pain

letrozole has been researched along with Low Back Pain in 1 studies

Low Back Pain: Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.

Research Excerpts

ExcerptRelevanceReference
"Letrozole was discontinued after 5."2.82Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature. ( Lüthje, P; Nurmi-Lüthje, I, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nurmi-Lüthje, I2
Lüthje, P2

Reviews

1 review available for letrozole and Low Back Pain

ArticleYear
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
    Journal of medical case reports, 2022, Dec-16, Volume: 16, Issue:1

    Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu

2022
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
    Journal of medical case reports, 2022, Dec-16, Volume: 16, Issue:1

    Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu

2022
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
    Journal of medical case reports, 2022, Dec-16, Volume: 16, Issue:1

    Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu

2022
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
    Journal of medical case reports, 2022, Dec-16, Volume: 16, Issue:1

    Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu

2022